Exploring your options for Blood Cancer Treatment (Leukemia, Lymphoma, Myeloma) in India? Ginger Healthcare brings together a carefully chosen panel of reputed hematologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Blood Cancer Treatment (Leukemia, Lymphoma, Myeloma). Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Here are the most reputed hospitals in India for Blood Cancer Treatment (Leukemia, Lymphoma, Myeloma). These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Blood cancer is an umbrella term for cancers that begin in the blood, bone marrow, or lymphatic system — including leukemia, lymphoma, and multiple myeloma. Unlike solid tumors, blood cancers are systemic, meaning cancer cells circulate throughout the body and cannot be removed by surgery alone. Treatment is therefore tailored to the specific cancer type, its subtype, genetic features, and the patient's overall fitness. The main treatment philosophies range from oral targeted therapy taken at home daily, to intensive inpatient chemotherapy, to stem cell transplantation that replaces diseased bone marrow entirely. Newer approaches such as CAR T-cell therapy and bispecific antibodies are available at specialist centers for relapsed or refractory disease. Most patients receive a coordinated combination of these modalities rather than a single treatment, and the plan evolves with the disease's response.
Daily oral tablets that block the specific molecular drivers of certain blood cancers, allowing many patients to manage their disease at home with periodic clinic monitoring rather than hospital admission.
Estimated cost: ~$500 – $1,000
Typical tests: CBC with differential and peripheral smear, Bone marrow biopsy and aspirate (if not recent), BCR-ABL PCR / molecular mutation panel (for CML/ALL), Flow cytometry and immunophenotyping, Renal function tests (KFT), liver function tests (LFT), Echocardiogram (cardiac baseline before TKI/BTK inhibitor), CT scan chest, abdomen, and pelvis (staging / baseline), Serum LDH, uric acid, beta-2 microglobulin. Done in India before admission.
Estimated cost in India: $3,000 – $8,000
Treatment duration in India: ~2 weeks (~5 hospital visit days across the full span)
Intensive multi-drug chemotherapy given during a prolonged hospital admission, designed to rapidly eliminate cancer cells and achieve remission — the primary approach for acute leukemias (AML, ALL) and aggressive lymphomas.
Estimated cost: ~$1,000 – $1,500
Typical tests: CBC with differential, reticulocyte count, peripheral smear, Bone marrow biopsy, aspirate, trephine biopsy, Cytogenetics (karyotype) and FISH panel, Molecular / NGS mutation panel (FLT3, NPM1, IDH1/2, TP53 etc.), Flow cytometry and immunophenotyping, CT scan chest, abdomen, pelvis (or PET-CT for lymphoma staging), Echocardiogram (cardiac baseline before anthracycline), KFT, LFT, coagulation profile (PT/INR/aPTT), serum LDH, uric acid, Lumbar puncture and CSF analysis (for ALL with CNS prophylaxis planning). Done in India before admission.
Estimated cost in India: $10,000 – $20,000
Pre-procedure stay (outside hospital): ~5 days
Hospitalisation: ~30 days
Recovery period (outside hospital): ~14 days recommended
Total stay: approx 49 days
Combination of chemotherapy with targeted monoclonal antibodies (such as rituximab for lymphoma or daratumumab plus bortezomib and lenalidomide for myeloma), delivered in repeating outpatient cycles over several months.
Estimated cost: ~$1,000 – $1,500
Typical tests: CBC with differential and peripheral smear, Bone marrow biopsy and aspirate (if not recent), PET-CT scan (for lymphoma staging) or CT chest, abdomen, pelvis, Serum protein electrophoresis and immunofixation (for myeloma), Beta-2 microglobulin, LDH, uric acid, KFT, LFT, calcium, phosphorus, Echocardiogram (baseline cardiac function), Flow cytometry and immunophenotyping, Hepatitis B and C serology (before rituximab / anti-CD20 therapy). Done in India before admission.
Estimated cost in India: $8,000 – $18,000
Pre-procedure stay (outside hospital): ~5 days
Hospitalisation: ~5 days
Recovery period (outside hospital): ~14 days recommended
Total stay: approx 24 days
A patient's own stem cells are collected before high-dose chemotherapy and reinfused afterwards to rescue the bone marrow — commonly used in multiple myeloma and relapsed lymphoma after initial treatment achieves remission.
Estimated cost in India: $20,000 – $45,000
For more details, visit: Bone Marrow Transplant (BMT) →
Stem cells from a matched donor replace the patient's diseased bone marrow, offering a graft-versus-leukemia immune effect — the most intensive treatment option, typically used in high-risk acute leukemia and certain lymphomas.
Estimated cost in India: $20,000 – $45,000
For more details, visit: Bone Marrow Transplant (BMT) →
The patient's own immune T-cells are genetically engineered in a laboratory to recognise and destroy cancer cells, then reinfused — a specialist centre treatment for blood cancers that have not responded to standard therapies.
Estimated cost in India: $35,000 – $60,000
For more details, visit: CAR-T Cell Therapy →
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
